US OptionsDetailed Quotes

IQV250117C230000

Watchlist

0.05
-0.08-61.54%

15min DelayClose Jan 17 16:00 ET

0.05High0.05Low

IQVIA Holdings Stock Discussion

Divided Sky

Jan 15 07:19

$IQVIA Holdings (IQV.US)$ Will be over 220 by the end of the month

areecep

Jun 7, 2024 02:52

Final Trades: Amazon, Goldman Sachs, AbbVie and IQVIA Holdings

$Warren Buffett Portfolio (LIST2999.US)$ $Berkshire Hathaway-A (BRK.A.US)$ $Berkshire Hathaway-B (BRK.B.US)$ $Amazon (AMZN.US)$ $AbbVie (ABBV.US)$ $IQVIA Holdings (IQV.US)$ $Goldman Sachs (GS.US)$

https://www.youtube.com/watch?v=_GqAmT6nEIU

From YouTube

Moomoo AI

Mar 7, 2024 05:08

Insiders' substantial share sale, especially by W. Staub and Constantinos Panagos, may worry shareholders. The lack of insider purchases over the past year could be a negative sign. Yet, high insider ownership might indicate well-aligned management incentives with shareholders.

Trade Alert: President of Research & Development Solutions Of IQVIA Holdings W. Staub Has Sold Stock

Divided Sky

Feb 14, 2024 07:10

$IQVIA Holdings (IQV.US)$ Aced the numbers again in a very competitive market

Moomoo AI

Feb 6, 2024 08:30

The market's opinion of the business has improved over the past five years, likely due to consistent earnings growth. Despite recent sell-offs, if fundamentals suggest sustainable long-term growth, this could be a worthwhile opportunity.

Those Who Invested in IQVIA Holdings (NYSE:IQV) Five Years Ago Are up 60%

Moomoo AI

Jan 7, 2024 06:29

IQVIA Holdings is currently undervalued and has a bright future. Its growth hasn't been fully factored into the share price. It may be a great time to increase holdings or enter the stock.

At US$221, Is It Time To Put IQVIA Holdings Inc. (NYSE:IQV) On Your Watch List?

Moomoo AI

Dec 7, 2023 11:46

Insiders selling shares, even below current price, hint they may deem shares not cheap. Coupled with no insider buying, this may serve as a warning to potential investors. High insider ownership, but recent sale history of IQVIA Holdings insiders could raise concern.

IQVIA Holdings Insiders Sell US$6.6m Of Stock, Possibly Signalling Caution

Moomoo AI

Oct 17, 2023 02:29

Bio-Rad Laboratories is likely to maintain an 80% market share in digital PCR products due to extensive offering and embracing continuous investment. Bio-Techne's extensive product offerings and the growth of its analytical instruments business are likely to drive its growth. For IQVIA, sales growth is primarily expected from managing its existing backlog.

Bio-Rad, IQVIA, Bio-Techne Among Top Picks at Credit Suisse

Moomoo Breakfast US

Feb 5, 2023 19:53

Columns What to Expect in the Week Ahead (Powell Speaks; DIS, PYPL and UBER Earnings)

Fourth-quarter earnings season continues this week, with close to 90 $S&P 500 Index (.SPX.US)$ companies scheduled to report. So far, earnings are down about 3% from the same period a year ago, per Refinitiv.
$Simon Property (SPG.US)$, $Take-Two Interactive Software (TTWO.US)$, and $Tyson Foods (TSN.US)$ report on Monday, followed by $BP PLC (BP.US)$, $DuPont (DD.US)$, and $Royal Caribbean (RCL.US)$.
$Disney (DIS.US)$, $CVS Health (CVS.US)$, and ...

Analysts Notebook

Nov 17, 2022 06:57

Columns US Top Rating Updates on 11/17: TGT, EL, ICE, IQV and More

Target Upgraded to Overweight From Neutral at Piper Sandler
Piper Sandler analyst Edward Yruma upgraded $Target (TGT.US)$ to Overweight from Neutral with a price target of $200, up from $190. The company has had a difficult 2022, but we are approaching "trough" EBIT margins and the stock's valuation now "looks compelling," Yruma tells investors in a research note.
Canaccord Starts Estee Lauder With Hold, Sees Estimate Risk
Canaccord analys...

No comment yet